Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into ... TheStreet.com, 4 days ago
LabCorp Is Scheduled To Present At The Morgan Stanley Global Healthcare Conference - TheStreet.com, 3 weeks ago
Epic Sciences announced an agreement with LabCorpto provide circulating tumor cell (CTC) technology and support oncology clinical trials inAsiathrough Covance Drug Development. Covance will process patient samples inSingapore, and then send samples ...Applied Clinical Trials, 2 months ago
Retired U.S. Army Gen. Stanley McChrystal Retired Army Gen. Stanley McChrystal asks three questions when he advocates for a year of service in which young people help their communities by joining programs such as Teach for America, AmeriCorps and ...Elon University, 5 days ago
Non Invasive Cancer Diagnostics and Technologies Market Trends, Company Share To 2022:Grand View Research, Inc.
Global is expected to witness lucrative growth in coming seven years owing to rising demand for minimally invasive therapeutics for treating cancer. Furthermore, rising prevalence of cancer as a consequence of unhealthy lifestyle and growing ...Digital Journal, 1 week ago Non-invasive Prenatal Testing Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022 Sys-Con Media, 3 weeks ago Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research Sys-Con Media, 2 months ago
by Dr. Irving Loh, MD There is a sea-change occurring in healthcare, brought about by healthcare technology now accessible by the consumer…I mean patient. The shift is going from physician controlled to patient controlled health data. I am not ...Sermo.com, 3 weeks ago
Eight Bridges Partners, LP performed well in July 2015, as our caution heading into the month was justified by subsequent market movements, particularly in small and mid-cap stocks. The Partnership returned 0.58% net of fees to Partners, ahead of ...Guru Focus, 1 month ago
Clinical Laboratory is Expected to Reach USD 148.82 billion by 2020, Growing at an Estimated CAGR of 6.8% from 2014 to 2020
Clinical laboratory tests are the fundamental basis upon which medical practitioners and healthcare providers form their diagnosis and prognosis for the prevention and treatment for a range of diseases, clinical laboratory tests are critical to the ...Digital Journal, 1 month ago
Google has announced that , as part of its Alphabet reshuffle, its life sciences team will become a standalone company that will work to get new technologies from the R&D stage to clinical testing. The team does not have an official name just yet. ...A2C2, 1 month ago Google X life-sciences division awaits name as it becomes Alphabet subsidiary SiliconValley.com, 1 month ago Alphabet spins out first company: The life sciences division of Google X MedCity News, 1 month ago L is for Life Sciences: Google's contact lens maker will be its own company NZ Reseller News, 1 month ago
The Center for Individualized Medicine at Mayo Clinic is investing in and partnering with a new startup, developing tools and technology to put consumers in control of their genomic data. [See also: Genomics pose 'daunting' test for EHRs] San ...HealthCareIT News, 1 month ago
Hatteras Venture Partners has reloaded, closing a new fund this morning to make a fresh round of investments in life science and health IT companies. The Durham, NC-based venture capital firm has raised more than $90 million for the fund, the ...Xconomy, 1 month ago
on your WebpageAdd Widget >Get your members hooked!